Arthur D. Little Launches Blue Shift Reports, Addresses Business Potential of Quantum Computing
Arthur D. Little (ADL) has published Unleashing The Business Potential Of Quantum Computing, the first in a series of new reports from the company running under the ‘Blue Shift’ banner. These reports will explore the impact of technologies on business, society and humans, covering relevant topics in depth and inviting guest authors, academics and artists to contribute to the conversation.
Unleashing The Business Potential Of Quantum Computing looks at the use cases for quantum computing (QC) as it develops and becomes commercially available.
QC promises to transform business by tackling intractable problems which are currently beyond the abilities of conventional high-performance computers. Potential QC-driven solutions include fully digitalized drug discovery and new materials development through to logistics, supply chain management, and portfolio optimization.
However, while there has been a major acceleration of development activity and investment in QC over the last few years, the path towards maturity is uncertain. QC technology is complex and hard for most people to properly understand, and there are still huge challenges to overcome.
This Blue Shift report from ADL aims to provide a clear overview of the state of play in QC for business readers unfamiliar with the domain, sharing not just potential use cases and applications, but also technology development, including hardware and software, and highlighting key players active in the QC ecosystem. It also provides a realistic perspective on the likelihood and possible timescales for the commercialization of QC.
In addition, the report sets out the steps that companies should take to prepare for the QC future, including exploring applicability, monitoring technical developments, engaging with the ecosystem, and building knowledge and capability.
Dr. Albert Meige, Director of Blue Shift at Arthur D. Little, comments: “Given the current state of play in QC, we recommend that companies take steps now to understand it, as once the technology starts to mature, those that have no internal capability could be especially disadvantaged. It is only by being prepared now that companies can avoid being left behind if and when QC properly takes off.”
Unleashing The Business Potential Of Quantum Computing can be viewed and downloaded here. Unleashing the business potential of quantum computing | Arthur D. Little (adlittle.com)
About Arthur D. Little
Arthur D. Little has been at the forefront of innovation since 1886. We are an acknowledged thought leader in linking strategy, innovation and transformation in technology-intensive and converging industries. We navigate our clients through changing business ecosystems to uncover new growth opportunities. We enable our clients to build innovation capabilities and transform their organizations.
Our consultants have strong practical industry experience combined with excellent knowledge of key trends and dynamics. ADL is present in the most important business centers around the world. We are proud to serve most of the Fortune 1000 companies, in addition to other leading firms and public sector organizations.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Further information from:
+44 7715 817589
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Airship Details Speakers for Elevate22, a Global Gathering of Mobile-First CXOs and Business Decision-Makers27.9.2022 13:37:00 CEST | Press release
Mobile app experience company Airship today announced speakers for Elevate22: Mastering MAX, an annual global forum for business leaders striving to create exponential value for both customers and brands through mobile apps. After two years of virtual gatherings, Elevate22 will take place on September 28 in New York City at Glasshouse Chelsea and in London on October 13 at Shoreditch Studios. Brand speakers include executives from Accenture, Bauer Media Group, BBC, Chipper Cash, CNET, DAZN, Disneyland Paris, Forrester Research, Inc., France TV, KeyBank, Kindred Group, Kingfisher plc, NBC Sports, OLIO, PayByPhone, SiriusXM, Southwest Airlines, Studio, YES Network and Zillow Group. Elevate22 programming is designed to both inspire and share proven strategies across the entire mobile app customer lifecycle, from acquiring customers and rethinking how to optimize life after download™, to optimizing the long game and navigating the changing data environment. The event is curated for executi
Aktana and Envision Pharma Group Partner to Help Medical Affairs Navigate the Evolving Physician Engagement Landscape27.9.2022 13:33:00 CEST | Press release
Aktana, the leader in intelligent customer engagement for the life sciences industry, and Envision Pharma Group, a global, technology-enabled scientific communications company operating across many areas of medical affairs, announce a strategic partnership that provides medical teams with a comprehensive toolkit for more impactful scientific exchange. By bringing together their extensive technical and industry expertise, Envision and Aktana offer life science companies the ability to enable their medical science liaisons (MSLs) to address HCP demands for personalized, scientifically relevant content and coordinated omnichannel engagement. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220927005291/en/ Despite the industry’s separation between commercial and medical teams, today’s HCPs expect MSLs to operate with a holistic view of their engagement with the product. While many life sciences companies have already started equi
FourKites Announces $10M Strategic Investment from Mitsui & Co. to Transform Supply Chains in Asia-Pacific27.9.2022 13:30:00 CEST | Press release
Leading supply chain visibility company FourKites today announces a $10M investment from Mitsui & Co., Ltd. to expand FourKites’ offerings across the APAC region. This investment encompasses the first phase in an ongoing strategic relationship between FourKites and Mitsui, which the two companies intend to formalise by the end of the year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220927005141/en/ FourKites Announces $10M Strategic Investment from Mitsui & Co. to Transform Supply Chains in Asia-Pacific (Graphic: Business Wire) Mitsui’s investment in FourKites is the culmination of a yearlong effort between the two companies, which included Mitsui’s extensive due diligence of the supply chain visibility landscape. Given FourKites’ market-leading offerings and proven track record in the region, Mitsui is planning to invest significant resources to expand FourKites’ coverage in APAC, including sales, customer service, oper
Forge Biologics Fuels Gene Therapy Manufacturing Engine with Launch of Plasmid DNA Manufacturing Services to Support AAV Clients27.9.2022 13:00:00 CEST | Press release
Forge Biologics, a gene therapy-focused contract development and manufacturing organization, today announced the new availability of plasmid DNA manufacturing to its suite of scalable manufacturing services for gene therapy programs, complementing Forge’s existing AAV process development, analytical development, cGMP manufacturing, and automated final fill capabilities. Forge’s plasmid manufacturing services encompass three grades to accommodate a phase-appropriate approach: Research-Grade, suitable for discovery, research and development; GMP-Pathway, suitable for early-stage clinical trial cGMP AAV manufacturing, and cGMP, suitable for late-stage clinical and commercial cGMP manufacturing. Forge’s plasmid production services utilize single-use systems that seamlessly integrate into the Company’s platform AAV manufacturing process, allowing continuity of manufacturing for clients and streamlined vendor management. Research-Grade and GMP-Pathway plasmid grades are currently available,
DOQMIND Announces Peter Hulsmans as CEO27.9.2022 13:00:00 CEST | Press release
DOQMIND (www.DOQMIND.com), a leading label and artwork management technology provider, announced today that Peter Hulsmans has been appointed CEO. With more than 20 years of label and artwork management leadership experience, Hulsmans brings a high-growth, customer-focused mindset to DOQMIND. “Peter’s experience and extensive industry knowledge make him the right person to build momentum and drive DOQMIND’s aggressive expansion plans,” said Ignace Cosaert, a board member of Athena Graphics, DOQMIND’s founding company. “Peter is known in the industry as someone who always delivers on his customer commitments, aligned with Athena’s reputation for delivering high-quality prepress services since 1991. He will be an excellent steward of our values, products, and brand portfolio.” DOQMIND has been providing label and artwork management technology to some of the most well-known brands for the last 15 years as part of Athena’s product portfolio. Its growth has positioned the company to spin of